Loading…
Operator of skilled nursing, senior living and rehabilitation facilities across the US, run under a decentralized local-operator model.
Operator of skilled nursing, senior living and rehabilitation facilities across the US, run under a decentralized local-operator model.
Operates each facility as a largely independent local business, with local leaders given autonomy and a share in results, and earns mostly from regulated Medicare and Medicaid payments per patient day. It improves facilities it buys by lifting quality and occupancy. It spun off CareTrust REIT in 2014 and Pennant Group, home health and hospice, in 2019.
Moat: narrow (scale, process know-how, distribution). Proven decentralized operating/acquisition model that consistently improves underperforming facilities it acquires.
Headquarters: San Juan Capistrano, California, USA · Founded: 1999 · Employees: 46,000
Size Ensign (ENSG) is a United States Health Care company (Medical/Nursing Services) with a market value of $10.6B, the 748th largest of 3,117 United States companies the cockpit tracks. Shares closed at $181.08 on 6 Nov 2026.
Performance Over six months the shares gained 5.6%, against +25.8% for the median peer and -1.1% for the United States market (cap-weighted) — 5th lowest of 20 in its peer set.
Growth Revenue grew 17.5% over the last twelve months (peer median +7.9%); the operating margin is 9.0% (peer median 9.8%).
Valuation It trades at 21.1× forward earnings against a peer median of 24.5× (10th cheapest of 20).
Price implies For today's price to make sense, revenue must grow about 12% a year for seven years (Req g). Recent delivered growth is +16%, so the hurdle is -4 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 1.4 points above its cost of capital (7.7% WACC).
Short interest Short interest is 2.4% of the free float (15 Oct 2026).
Next results Next results expected around 10 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $5.67B | $5.06B | $4.26B | $3.66B | $2.94B |
| Revenue growth | — | +19% | +16% | +24% | — |
| Gross profit | $820M | $695M | $585M | $454M | $374M |
| EBITDA | $632M | $538M | $445M | $264M | $277M |
| Net income | $399M | $344M | $298M | $209M | $225M |
| Free cash flow | $510M | $371M | $189M | $270M | $182M |
| Capital expenditure | $186M | $194M | $158M | $106M | $87.5M |
| Total debt | $2.29B | $2.21B | $1.97B | $1.87B | $1.57B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Ensign ENSG | $10.6B | +6% | +17% | 9% | 21.1× | 12.0% |
| National HealthCare NHC | $3.27B | +11% | +7% | -8% | n/a | 7.9% |
| Brookdale Senior Living BKD | $2.15B | -31% | -4% | 5% | 127.7× | 22.4% |
| PACS PACS | $7.87B | +48% | +11% | 8% | 19.2× | 7.6% |
| Pennant PNTG | $1.27B | +1% | +38% | 6% | 24.0× | 21.1% |
| Sonida Senior Living SNDA | $1.58B | -14% | +49% | -11% | n/a | n/a |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | ENSG | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +5.6% | +10.9% | 7th lowest of 21 |
| 6-month return | +5.6% | +25.8% | 5th lowest of 20 |
| Distance from 52-week high | -16.9% | -10.2% | 8th lowest of 21 |
| Revenue growth (TTM) | +17.5% | +7.9% | 7th highest of 21 |
| Operating margin | 9.0% | 9.8% | 9th lowest of 21 |
| Forward P/E | 21.1× | 24.5× | 10th cheapest of 20 |
| Growth the price implies (Req g, 7 yrs) | 12.0% | 12.8% | 10th least demanding of 19 |
| Growth delivered (Del g) | +16.5% | +12.5% | 7th highest of 19 |
| Hurdle (Req g minus delivered) | -4.5 pp | +0.5 pp | 6th least demanding of 19 |
| ROIC minus cost of capital | +1.4 pp | +0.6 pp | 10th highest of 21 |
| EV / EBITDA | 19.7× | 13.9× | 5th most expensive of 16 |
| Net debt / EBITDA | 3.0× | 2.8× | 8th most indebted of 19 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Ensign ENSG | United States | $10.6B | +6% | +17% | 9% | 21.1× | 12.0% | +16.5% |
| DaVita DVA | United States | $12.0B | -4% | +6% | 15% | 11.9× | -1.1% | +3.4% |
| Aier Eye Hospital 300015.SZ | China | $12.5B | -16% | +5% | 21% | 29.5× | 11.7% | +13.4% |
| Fresenius Medical Care FME.DE | Germany | $12.6B | +14% | 0% | 11% | 10.4× | -3.6% | +1.9% |
| BrightSpring Health Services BTSG | United States | $13.4B | +22% | +23% | 4% | 28.3× | 24.2% | +18.3% |
| Encompass Health EHC | United States | $13.5B | +30% | +9% | 18% | 20.5× | 5.6% | +5.0% |
| Solventum SOLV | United States | $15.4B | +23% | -1% | 8% | 12.2× | n/a | n/a |
| Sonic Healthcare SHL.AX | Australia | $6.87B | +6% | +14% | 9% | 16.8× | 8.6% | +3.5% |
| Hims & Hers Health HIMS | United States | $6.07B | -8% | +28% | 0% | 128.9× | 54.9% | +73.6% |
| RadNet RDNT | United States | $5.98B | +31% | +19% | 5% | 129.7× | 41.8% | +13.7% |
| Concentra Group Holdings Parent CON | United States | $5.38B | +75% | +14% | 17% | 24.5× | 3.9% | +7.9% |
| BillionToOne BLLN | United States | $5.38B | +54% | +90% | 11% | 144.4× | 26.8% | +90.1% |
| Lifestance Health LFST | United States | $5.26B | +79% | +20% | 5% | 62.6× | 37.8% | +30.4% |
| Option Care Health OPCH | United States | $4.74B | +54% | +4% | 6% | 15.6× | 1.5% | +13.2% |
| Medicover MCOV-B.ST | Sweden | $4.14B | +36% | +6% | 7% | 38.3× | 20.8% | +20.2% |
| Labcorp LH | United States | $29.8B | +45% | +6% | 11% | 19.0× | 13.9% | 0.0% |
| Koninklijke Philips PHIA.AS | Netherlands | $29.8B | +24% | -1% | 10% | 16.5× | 5.7% | +0.6% |
| Dr. Lal PathLabs LALPATHLAB.NS | India | $3.50B | +26% | +17% | 24% | 51.5× | 32.2% | +11.8% |
| Acadia Healthcare ACHC | United States | $3.44B | +47% | +4% | 10% | 18.7× | n/a | n/a |
| Fameglow 3774.HK | Hong Kong | $3.19B | n/a | +36% | 11% | n/a | 48.8% | +48.4% |
| Meinian Onehealth Healthcare 002044.SZ | China | $2.89B | -9% | -4% | 9% | 55.1× | 5.8% | +5.7% |